Traditional prenatal testing methods are highly intrusive in nature causing major health issues for the expectant mothers as well as for the fetus. This risk is higher in case the mother is at an advanced age of her life to bear a child leading to a whole new set of complications. This has resulted in increased research in the field of medicine and the invention of non-passive prenatal testing. The rise in demand for non-invasive prenatal testing (NIPT) has boosted the global market for NIPT. The NIPT market valued US$ 0.53 bn at the end fo 2013 and is projected to reach US$2.38 bn at the end of the forecast period of 2015 up to 2022, growing at a staggering 15.0%.
Reduced Risk of Miscarriage Driving Global Non-invasive Prenatal Testing Market
The idea behind prenatal testing is to check for the health of the baby at a chromosomal level to make sure the baby will not be born with any of the genetic abnormalities such as Down syndrome, Patau syndrome, Turner syndrome, and Edwards syndrome. The traditional testing methods included chorionic virus sampling and amniocentesis. The tests had low accuracy and with the samples being taken from the amniotic liquid, the risk of miscarriage was high, which is not the case with NIPT. NIPT uses cell-free DNA available in the maternal plasma. Hence the risk of miscarriage is zero. NIPT is being widely adopted by the doctors all over and is driving the global non-invasive prenatal testing market.
Looking for Details Report TOC: http://www.persistencemarketresearch.com/market-research/non-invasive-prenatal-testing-nipt-market/toc
NIPT Market Furthering Rate of Healthy Newborns
NIPT is also gaining wide importance due to rise in the age of women bearing a child. The shift in market trend is the result of largely hectic lifestyles and career-oriented approach of the spouses. Also, the increased inflation and monetary issues is pushing the age of child bearing further leading to an increased demand for non-invasive prenatal testing.
With NIPT testing expectant parents can have a clear idea about the health of the baby genetically beforehand. In case the results show a positive in case of any of the genetic syndromes, the parents can make an informed decision about the fetus. Also with no risks of miscarriage in case of NIPT, there is significant rise in the number of healthy newborns.
Drop in Rate of False Positive with NIPT
With conventional testing method, the accuracy of the results were low leading to a lot of false positives in the case of results. Many a times the test results indicated a positive for Down syndrome, but it was not the case in reality. This resulted in rash decisions being taken by the doctors and the expectant parents regarding the future of the baby. In the case of non-invasive prenatal testing, the false positives account to only 0.1% of the total tests conducted. Hence, the parents are able to make an informed decision about the future of the fetus and hence the test is being widely adopted, driving the global non-invasive prenatal testing market.
Interested to know more? Follow the link: http://www.persistencemarketresearch.com/samples/11218
Key market players in the global non-invasive prenatal testing market include Laboratory Corporation of America Holdings (LabCorp), BGI Diagnostics, Berry Genomics, Illumina, Inc. (Verinata Health, Inc. acquired), LifeCodexx AG, Sequenom, Inc., Ariosa Diagnostics, and Natera, Inc.